Do you want to research at the Department of Neuroscience?

Our groups of researcher are continuously loooking for new collaborative partners, post-doctoral fellows, Ph.D. students and project students. We are able to offer a range of different projects that can be tailored to your interests. Read more about our groups of researchers and contact our group leaders.

Read more about our recruitment here.


Uppsala Psychiatric Patient samples (UPP)

Uppsala Psychiatric Patient samples (UPP): Prospective Collection of Samples for the Study of Biological Mechanisms in Clinical Psychiatry.


Current clinical practice in psychiatry is conducted through subjective evaluation of phenotypes. Diagnostic instruments, such as structured interviews and questionnaires, greatly improve the sorting of patients into valid diagnostic groups where generalizations about etiology and appropriate treatment can be made reliably. Biological markers are, however, absent and an important dimension of diagnostics is missing. There has been an exponential increase in publications that demonstrate correlations between circulating levels of signaling substances such as hormones and cytokines to psychiatric symptom. Recent studies, for example, demonstrate elevated cytokine-levels in acutely suicidal patients and changes in cytokine levels can be followed to monitor treatment response(Lindqvist et al., 2009). Other results demonstrate autoimmune processes with targets in neural tissue that manifest with psychiatric symptoms (Sabin et al., 2008). Although these findings are still young and must be verified before widespread clinical is feasible, they imply the presence of a whole new frontier where genetics, endocrinology, immunology and psychiatry meet.

Ethical approval for the following project was obtained in spring, 2012. “Uppsala psykiatrisk provsamling” or Uppsala Psychiatric Patient samples (UPP) was launched in October as a pilot project.

Major Aims

The first aim is to create an infrastructure for the collection of biological material from patients with psychiatric symptoms. The infrastructure would enable systematic collection of material from patients before treatment start and regularly during treatment. This step is essential to:

-identify diagnostic biological markers (including genetic, hormonal, inflammatory markers) for disease

-identify differences between diagnosis groups

-follow biological changes induced by treatment.

-conduct case studies on selected patients (see below)


The second aim is to improve collaboration in biological research within psychiatry by increased knowledge about how to optimize patient’s integrity.




Project leader:

Janet Cunningham, Associate Professor



Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours, pubicerad i PLOS ONE
Fanny Söderquist1, Eva Tiensuu Janson2, Annica J. Rasmusson3, Abir Ali2,
Mats Stridsberg4, Janet L. Cunningham1*

Klicka här för att läsa mer om Melatoninom? – höga nivåer av melatonin i neuroendokrina neuroendokrina tumörer i tarmen

"Salivary Melatonin in Relation to Depressive Symptom Severity in Young Adults" publicerad i PLOS ONE

Isak Sundberg1, Mia Ramklint1, Mats Stridsberg2, Fotios C. Papadopoulos1, Lisa Ekselius1, Janet L. Cunningham1*1 Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden, 2 Departm